Product Development Lab

Innovation is in your DNA. It’s in ours, too. For more than a decade, Alira Health has provided high quality services to clients in acute and non-acute care settings, delivering planning, development, and commercialization solutions including:

IP Development: StructuredIP™	In Vitro and In Vivo Testing
CMC Manufacturing Strategy and Operations	CMC Process Development and Optimization
CMC Outsourcing Support	CMC GMP Facility Design
CMC Project Integration	CMC Technical and GMP Training

Leverage our dedicated, in-house lab

The Alira Health Product Development lab combines scientific expertise with business acumen to guide healthcare innovations from discovery to commercialization. The lab is led by Mitchell Sanders, MS, PhD. Dr. Sanders has spent 30 years working with preclinical animal models and clinical product development in advanced wound care.

Our in-house product development lab provides:

An onsite biosafety level II (BSL-2) facility with an exhaustive library of clinical bacteria isolates

Cell models for inflammation, migration, 3D tumor and apoptosis

Gene expression (qPCR) and immunocytochemistry

Microbiology and biofilm models

Expertise in wound healing and infection prevention

Fluorescent and colorimetric microplate assays

Preclinical animal models

Product Development that humanizes healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Mitchell Sanders, PhD

Chief Scientific Officer

Our fully dedicated lab team delivers faster execution and better accountability, accelerating commercialization with major milestones to drive better valuations and ROIs.